Company intelligence / Profile preview

Shenyang Hongqi Pharmaceutical Co., Ltd.

Shenyang, Liaoning, Chinaen.hongqipharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Shenyang Hongqi Pharmaceutical is a leading Chinese pharmaceutical company specializing in anti-tuberculosis drugs. Founded in 1964, it became a subsidiary of Shanghai Fosun Pharmaceutical Group in 2010. The company has developed and commercialized first-line and second-line anti-TB medications—including rifampicin, isoniazid, ethambutol hydrochloride, pyrazinamide tablets—and is advancing innovative therapies such as PA‑824/pretomanid. Its products have passed WHO prequalification standards where applicable. The company serves both domestic Chinese markets and international customers through exports.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculesAntibiotics/antibacterialsCombination drugs for tuberculosis
Industry: Biotech

Drug pipeline

4 assets

rifampicin

Commercial

Indications: Tuberculosis

3 more assets in the full pipeline.

Request access →

Partnerships

Parent partnership with Shanghai Fosun Pharma.Collaboration with Shenzhen National Infectious Diseases Clinical Medical Research Center.Involved with China Anti-TB Association innovation base projects.

Beyond the preview

Go deeper on Shenyang Hongqi Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenyang Hongqi Pharmaceutical Co., Ltd..

Explore the full profile